2008
DOI: 10.1016/j.jinorgbio.2007.11.021
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, siderophore activity and iron(III) chelation chemistry of a novel mono-hydroxamate, bis-catecholate siderophore mimic: Nα,-Nε-Bis[2,3-dihydroxybenzoyl]-l-lysyl-(γ-N-methyl-N-hydroxyamido)-l-glutamic acid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 39 publications
0
7
0
Order By: Relevance
“…Unlike Desferal, but in a similar fashion to enterobactin, 3,4‐LICAMS was able to kinetically mobilize iron from transferrin in vitro, and showed that a rational strategy may be used for the design of ligands with optimal metal chelating properties 335, 338. Research has also focused on the synthesis of mixed‐ligand siderophores, in which at least one chelating moiety is catecholic, for example mono‐catechol bis‐hydroxamate‐339 and bis‐catechol mono‐hydroxamate ligands 339, 340. Other catechol‐based ligands, such as 2,3‐dihydroxyterephtalamide, have been used to prepare pure‐ and mixed‐ligand siderophores with a very high affinity for Fe III , while at the same time being stable to oxidation and presenting low acidity 341.…”
Section: Siderophore‐like Materialsmentioning
confidence: 99%
See 1 more Smart Citation
“…Unlike Desferal, but in a similar fashion to enterobactin, 3,4‐LICAMS was able to kinetically mobilize iron from transferrin in vitro, and showed that a rational strategy may be used for the design of ligands with optimal metal chelating properties 335, 338. Research has also focused on the synthesis of mixed‐ligand siderophores, in which at least one chelating moiety is catecholic, for example mono‐catechol bis‐hydroxamate‐339 and bis‐catechol mono‐hydroxamate ligands 339, 340. Other catechol‐based ligands, such as 2,3‐dihydroxyterephtalamide, have been used to prepare pure‐ and mixed‐ligand siderophores with a very high affinity for Fe III , while at the same time being stable to oxidation and presenting low acidity 341.…”
Section: Siderophore‐like Materialsmentioning
confidence: 99%
“…In order to minimize resistance by receptor‐deficient mutants, mixed‐ligand siderophore‐drug conjugates intended to target multiple receptors have been tested, for example carbacephalosporins bearing bis‐catechol‐mono‐hydroxamate hybrid siderophores 377–380. It was suggested that selected mutant strains showing resistance would be, at the same time, severely iron‐deprived for lack of proper iron‐uptake routes, which would make them intrinsically less virulent.…”
Section: Siderophore‐like Materialsmentioning
confidence: 99%
“…Growth promotion assays under iron depletion, using a panel of siderophore indicator strains, were applied to demonstrate the recognition of the iron complexes by outer membrane siderophore receptors with a subsequent translocation across the membrane and a release of the iron. (Schumann and Möllmann 2001;Mies et al 2008) The most active siderophore analogues were selected as vectors for the synthesis of drug conjugates.…”
Section: Synthesis and Analysis Of Siderophore Analogs And Their Drugmentioning
confidence: 99%
“…90 In contrast, other siderophore mimics resemble the 'natural' function of siderophores and hence promote bacterial growth by delivering iron ions to these organisms. 91 Jean-Louis Pierre and colleagues have recently reviewed aspects of synthetic siderophore mimics and their potential therapeutic uses. 92,93 The lead structures for iron chelators identified at the time, further developments since then and the design criteria for such oral chelators have recently been reviewed by Robert Hider and colleagues (Fig.…”
Section: Strategies To Lower the Labile Ion Poolsmentioning
confidence: 99%